Extrawell Pharmaceutical Holdings Limited (0858) Stock Statistics & Valuation Metrics

Extrawell Pharmaceutical Holdings Limited has a market cap or net worth of HK$298.75M. The enterprise value is -HK$725.99M.

Extrawell Pharmaceutical Holdings Limited has 2,390,000,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Extrawell Pharmaceutical Holdings Limited’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is -0.60%.

The current PE Ratio of Extrawell Pharmaceutical Holdings Limited is 1.4. Extrawell Pharmaceutical Holdings Limited’s PEG ratio is ―.

In the last 12 months, Extrawell Pharmaceutical Holdings Limited had revenue of 55.43M and earned 222.64M in profits. Earnings per share was 0.09.

In the last 12 months, operating cash flow was 2.81M and capital expenditures -1.20M, giving a free cash flow of 1.61M billion.

Extrawell Pharmaceutical Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Extrawell Pharmaceutical Holdings Limited upcoming earnings date is Nov 28, 2025, TBA (Not Confirmed).

Extrawell Pharmaceutical Holdings Limited as a current ratio of 21.91, with Debt / Equity ratio of 10.56%

In the past 12 months, Extrawell Pharmaceutical Holdings Limited has paid 1.17M in taxes.

Extrawell Pharmaceutical Holdings Limited EV to EBITDA ratio is 0.67, with an EV/FCF ratio of -22.94.

Extrawell Pharmaceutical Holdings Limited has HK$870.44M in cash and marketable securities with HK$130.18M in debt, giving a net cash position of -HK$740.26M billion.

Gross margin is 39.46%, with operating margin of -16.08%, and net profit margin of 401.67%.

The average price target for Extrawell Pharmaceutical Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is Hold